Table 1

HC gp39 and CRP serum levels in: IBD-A, IBD-nonA, aIBD, and naIBD subgroups with and without arthritis

SubgroupsPatients (n)HC gp39 (ng/ml)CRP (mg/l)
Serum levels of HC gp39 and CRP in aIBD-A, naIBD-A, aIBD-nonA, naIBD-nonA, and controls. The Kruskal-Wallis analysis: v naIBD-nonA *p<0.05, †p<0.01, ‡p<0.001; v controls §p<0.05, ¶p<0.001.
aIBD-A20122.6 (78.6)‡§24.5 (35)¶
naIBD-A43105.8 (97.6)†10.4 (14)¶
aIBD-nonA1672.6 (49)22.4 (18.5)*¶
naIBD-nonA4258.4 (49.4)5.1 (6.1)§
Controls2051.9 (14.1)1.3 (1.5)